Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: J Clin Apher. 2018 Mar 10;33(4):469–479. doi: 10.1002/jca.21622

Table I.

Demographics of TPE vs. Non-TPE Treated Cardiac Transplant Patients

TPE-treated
N = 109
N (%)
Non-TPE Treated
N = 204
N (%)
p

Age (years), mean, SD 48, 19 51, 19 0.45
 Range 4 mos. – 76 yrs. 2 mos. – 74 yrs.

Pediatric patients (Age < 18) 11 (10) 20 (10) 0.94

Sex < 0.0001
 Males 59 (54) 158 (77)
 Females 50 (46) 46 (23)

Race 0.0009
 White/Caucasian 56 (51) 142 (70)
 Black/African American 48 (44) 48 (23)
 Other 5 (5) 14 (7)

Transplant year 0.06
 2010 22 (20) 36 (18)
 2011 28 (26) 32 (16)
 2012 17 (16) 47 (23)
 2013 24 (22) 37 (18)
 2014 18 (16) 52 (25)

Transplant indication
 Non-ischemic cardiomyopathy 58 (53) 90 (44)
 Ischemic cardiomyopathy 34 (31) 86 (42) 0.02
 Congenital Heart Defect 12 (11) 9 (5)
 Other 5 (5) 19 (9)

Post-transplant infection present 42 (39) 76 (37) 0.82

TPE = Therapeutic plasma exchange; N = Number; SD = Standard deviation; mos. = months; yrs. = years; p-values calculated using two-sample t-test and chi-square test of independence as appropriate.